Table of Contents
ISRN Oncology
Volume 2011 (2011), Article ID 527904, 6 pages
http://dx.doi.org/10.5402/2011/527904
Clinical Study

Axillary Dissection in Breast Cancer Patients with Metastatic Sentinel Node: To Do or Not to Do? Suggestions from Our Series

1Ginteam, Mini-Invasive Gynaecological and Breast Unit, Evangelical Hospital, ASL TO1, Corso Marconi 35, 10125 Torino, Italy
2Breast Radiology Unit, Evangelical Hospital, ASL TO1, Torino, Italy

Received 10 April 2011; Accepted 20 May 2011

Academic Editor: C. Perez

Copyright © 2011 M. Bortolini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Giuliano, D. M. Kirgan, J. M. Guenther, and D. L. Morton, “Lymphatic mapping and sentinel lymphadenectomy for breast cancer,” Annals of Surgery, vol. 220, no. 3, pp. 391–401, 1994. View at Google Scholar
  2. B. J. Grube and A. E. Giuliano, “Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial,” Seminars in Surgical Oncology, vol. 20, no. 3, pp. 230–237, 2001. View at Publisher · View at Google Scholar · View at PubMed
  3. R. E. Mansel, L. Fallowfield, M. Kissin et al., “Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial,” Journal of the National Cancer Institute, vol. 98, no. 9, pp. 599–609, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. “The NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesTM) Breast Cancer (Version 1.2010),” National Comprehensive Cancer Network, Inc., 2010, http://www.nccn.org/index.asp.
  5. G. H. Lyman, A. E. Giuliano, M. R. Somerfield et al., “American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer,” Journal of Clinical Oncology, vol. 23, no. 30, pp. 7703–7720, 2005. View at Publisher · View at Google Scholar · View at PubMed
  6. U. Veronesi, G. Viale, G. Paganelli et al., “Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study,” Annals of Surgery, vol. 251, no. 4, pp. 595–600, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. M. Yi, S. H. Giordano, F. Meric-Bernstam et al., “Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: Experience from the SEER database,” Annals of Surgical Oncology, vol. 17, supplement 3, pp. S343–S351, 2010. View at Publisher · View at Google Scholar · View at PubMed
  8. A. E. Giuliano, L. McCall, P. Beitsch et al., “Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group z0011 randomized trial,” Annals of Surgery, vol. 252, no. 3, pp. 426–432, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. B. J. Grube and A. E. Giuliano, “Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial,” Seminars in Surgical Oncology, vol. 20, no. 3, pp. 230–237, 2001. View at Publisher · View at Google Scholar · View at PubMed
  10. B. Unal, A. S. Gur, O. Kayiran et al., “Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system,” International Journal of Clinical Practice, vol. 62, no. 11, pp. 1785–1791, 2008. View at Publisher · View at Google Scholar · View at PubMed
  11. M. P. Moore and D. W. Kinne, “Axillary lymphadenectomy: a diagnostic and therapeutic procedure,” Journal of Surgical Oncology, vol. 66, no. 1, pp. 2–6, 1997. View at Publisher · View at Google Scholar
  12. A. E. Giuliano, K. K. Hunt, K. V. Ballman et al., “Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial,” Journal of the American Medical Association, vol. 305, no. 6, pp. 569–575, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. M. E. Straver, P. Meijnen, G. Van Tienhoven et al., “Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer,” Journal of Clinical Oncology, vol. 28, no. 5, pp. 731–737, 2010. View at Publisher · View at Google Scholar · View at PubMed
  14. M. De Boer, C. H. M. Van Deurzen, J. A. A. M. Van Dijck et al., “Micrometastases or isolated tumor cells and the outcome of breast cancer,” New England Journal of Medicine, vol. 361, no. 7, pp. 653–663, 2009. View at Publisher · View at Google Scholar · View at PubMed
  15. F. Rovera, F. Frattini, C. Chiappa et al., “The role of micrometastatic disease in sentinel lymph node in breast cancer,” Breast Journal, vol. 16, no. 1, pp. S26–S28, 2010. View at Publisher · View at Google Scholar · View at PubMed
  16. K. Y. Bilimoria, D. J. Bentrem, N. M. Hansen et al., “Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer,” Journal of Clinical Oncology, vol. 27, no. 18, pp. 2946–2953, 2009. View at Publisher · View at Google Scholar · View at PubMed
  17. B. P. Baruah, A. Goyal, P. Young, A. G. Douglas-Jones, and R. E. Mansel, “Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer,” British Journal of Surgery, vol. 97, no. 5, pp. 680–683, 2010. View at Publisher · View at Google Scholar · View at PubMed
  18. U. Veronesi, R. Orecchia, S. Zurrida et al., “Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy,” Annals of Oncology, vol. 16, no. 3, pp. 383–388, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at PubMed
  20. S. Yegiyants, L. M. Romero, P. I. Haigh, and L. A. DiFronzo, “Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node,” Archives of Surgery, vol. 145, no. 6, pp. 564–569, 2010. View at Publisher · View at Google Scholar · View at PubMed
  21. A. Recht, S. B. Edge, L. J. Solin et al., “Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology,” Journal of Clinical Oncology, vol. 19, no. 5, pp. 1539–1569, 2001. View at Google Scholar